Erminia Ridolo
University of Parma
205 Papers
1.1K Citations
Erminia Ridolo is an academic researcher from University of Parma. The author has contributed to research in topics: Medicine & Asthma. The author has an hindex of 35, co-authored 174 publications.
Chat about Author
Papers
Are IgE levels to foods other than rosaceae predictive of allergy in lipid transfer protein-hypersensitive patients?
Riccardo Asero,A. Arena,Lorenzo Cecchi,M.E. Conte,Mariangiola Crivellaro,F Emiliani,F. Lodi Rizzini,R. Longo,P. Minale,F Murzilli,Antonino Musarra,F. Nebiolo,O Quercia,Erminia Ridolo,Eleonora Savi,Gianenrico Senna,Danilo Villalta +16 more
TL;DR: Investigation of the relevance of IgE levels to some plant foods other than Rosaceae as predictors of either local or systemic allergic reaction in LTP-allergic subjects found specific IgE Levels are only partially predictive of clinical allergy.
Striving for optimal bronchodilation: focus on olodaterol.
Cristoforo Incorvaia,Marcello Montagni,Elena Makri,Gian Galeazzo Riario-Sforza,Erminia Ridolo +4 more
TL;DR: In controlled trials, olodaterol was shown to be as effective as formoterol twice daily, but significantly superior in terms of quality of life in patients with COPD.
Age dependent differences in anaphylaxis: elderly population.
A. Barone,Francesca Nicoletta,Martina Ottoni,Erminia Ridolo +3 more
TL;DR: Elderly individuals exhibit age-dependent differences in anaphylaxis, with drugs and insect venom as primary triggers, and increased risk of severe reactions due to comorbidities and complex medication regimens.
Correction: Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan.
Carlo Lombardi,Pasquale Comberiati,Erminia Ridolo,M. Cottini,Mona-Rita Yacoub,Silvia Casagrande,Matteo Riccò,Marco Bottazzoli,Alvise Berti +8 more
Safety and adverse reactions in subcutaneous allergen immunotherapy: a review
Cristoforo Incorvaia,Carlo Cavaliere,Jan Walter Schroeder,Gualtiero Leo,Francesca Nicoletta,A. Barone,Erminia Ridolo +6 more
TL;DR: The safety of SCIT is good, but the research to improve it further must continue, based on the evident diversity demonstrated by the complete absence of fatal reactions to Hymenoptera venom immunotherapy from its introduction in comparison with the history of serious and fatal offenses examined in this review.